Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer - Test2 - elhamkhani - TriplyDB

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

http://www.wikidata.org/entity/Q24528253

about

Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis Cancer as a metabolic disease MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 Evaluation of protein biomarkers of prostate cancer aggressiveness The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex PTEN inhibits BMI1 function independently of its phosphatase activity The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis New molecularly targeted therapies for lung cancer Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins Evaluation of reference-based two-color methods for measurement of gene expression ratios using spotted cDNA microarrays.Actions of Thyroid Hormone Analogues on Chemokines Ubiquitin-specific peptidase 22 functions and its involvement in disease Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy Genome-wide analysis of microRNA and mRNA expression signatures in cancer Biological features and biomarkers in hepatocellular carcinoma Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer Hippo/YAP pathway for targeted therapy Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells Deficiency in the nuclear-related factor erythroid 2 transcription factor (Nrf1) leads to genetic instability A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy A meta-analysis approach for characterizing pan-cancer mechanisms of drug sensitivity in cell lines Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides Polycomb silencers control cell fate, development and cancer Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

P2860

Q21136141-D6942484-857B-4941-9069-D9987B3BE545 Q21245061-C72BC303-18C8-4A51-AB2C-B900C9BA6032 Q21245764-93A70E0B-EF7E-4179-99C1-A2FC54E61054 Q21261257-28BB4CC1-BE15-48F7-9D3E-42A5FA8D1387 Q24307439-9DA1A26F-AED6-49C3-9F92-EC42807D668B Q24311562-8F135150-ED5D-4B30-8DFD-4212A7E31C22 Q24314096-7808A67D-FF07-4502-BFF0-91251777F7E7 Q24315949-49289A98-51B6-4F18-A7FB-72EA7CC618B6 Q24318500-031D047C-E05C-413B-B9F1-26B32F179673 Q24632636-7FF8387D-9158-453E-A3E3-AF2BA26B2268 Q24646412-288EBD2A-6843-49DD-9586-1C397708BCBB Q24654211-2F89FD30-BD58-4929-B259-7BFEB6D69699 Q24657877-F84C4CF8-5E35-4A57-B9FD-4ABD0B6FB773 Q24675945-EFDBF127-006D-4A95-A5E3-8A1428F043AF Q24680988-BADF1285-5BE7-4D46-93B5-3AF55106C300 Q24681882-C0A176FC-829F-4B36-9A94-F9ED1FD55EAB Q25255703-BFDC108F-E0F8-4871-9D1C-594A2B9BA45E Q26738767-DB32195E-F5EF-4F4C-BAB5-F1D8573A59EC Q26750743-E07F005B-49A0-42D7-8126-64853D6B7963 Q26775961-B4A2253D-8258-4ABF-AFA1-D7D4B94B6590 Q26795603-5BA97829-F131-4B93-BB92-AB52848ADC89 Q26799462-2E422B0A-081B-41F7-95EB-1E9C48154CF5 Q26822406-39866842-D51B-4D80-9BBC-436A29D19652 Q26849477-50A80123-7AD8-4C6F-A634-797951599E2C Q26995347-CBBAEEFD-F084-40EA-8AD7-6D85E39251B0 Q27022720-F6556CCA-5BE2-481F-B8CC-6FB672313303 Q27335110-D1AAE196-49FC-443B-AAA2-EA39FD631873 Q27438119-CB611B74-99DA-4261-A6B5-D59E02FF258C Q28075362-85C0078F-BC75-4613-8DAD-72500E4C912F Q28088294-3D2380E7-56BF-4E47-B90E-6E70BB2AB4E5 Q28246460-5A240811-C480-4522-8C44-D50F22E41892 Q28274930-ECE9A500-6138-44AE-828E-92E3BD67C4FD Q28387995-0932D6A8-A9E8-45CA-8B3D-9163888394B9 Q28484295-836F44E9-9771-4760-B651-738FB1BA790D Q28488474-E1F4CB58-7BA3-4259-B865-67D2B6B8E428 Q28534277-793B91FA-559D-4DCB-B5D9-73AACA0E4D4F Q28540936-04BD6E07-A4FE-4381-9DBC-B21594352B37 Q28731283-DD9EAB4B-E843-42FB-962F-7FB3CBBB8FD5 Q29619697-F4E1329D-DC17-47F1-AA14-549F328B5A55 Q29622952-B8169C63-F5FB-4D39-9048-C1AC28BFA21A

P2860

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

http://www.wikidata.org/entity/Q24528253

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Microarray analysis identifies ...... with multiple types of cancer

@ast

Microarray analysis identifies ...... with multiple types of cancer

@en

Microarray analysis identifies ...... with multiple types of cancer

@en-gb

Microarray analysis identifies ...... with multiple types of cancer

@nl

type

label

Microarray analysis identifies ...... with multiple types of cancer

@ast

Microarray analysis identifies ...... with multiple types of cancer

@en

Microarray analysis identifies ...... with multiple types of cancer

@en-gb

Microarray analysis identifies ...... with multiple types of cancer

@nl

prefLabel

Microarray analysis identifies ...... with multiple types of cancer

@ast

Microarray analysis identifies ...... with multiple types of cancer

@en

Microarray analysis identifies ...... with multiple types of cancer

@en-gb

Microarray analysis identifies ...... with multiple types of cancer

@nl

P1433

Q24528253-6E0CCE88-6BD7-4ABE-AD67-6B65CD46572A

P1476

Q24528253-C2A649DF-5FCF-4029-855A-3D4A9747E00A

P2093

Q24528253-25677B18-D170-4BB3-90AB-7EF0E458EB99

Q24528253-52CBF047-9BBD-4A3F-B9A7-EE866709477F

Q24528253-5826E09B-D474-48E4-B6A4-379FA57230D5

P2860

Q24528253-02E07C65-3088-4CCE-89C0-6D4F6EA25AFA

Q24528253-0A8F408F-592E-4ED8-9950-F40C8095F87A

Q24528253-0E9389A9-4984-4FD0-AA10-764EA524C859

Q24528253-15BEC58C-473A-434C-919E-E9355B3F82B1

Q24528253-16706F95-48CA-4BBC-B0CE-58D9D55C624E

Q24528253-1A33B707-709E-4D2C-8E63-89D5FA4D1751

Q24528253-1AC1C1E1-175A-409A-A474-A00E2DFE9A52

Q24528253-2EC5ADD4-AC09-49F8-8138-23442498F3F9

Q24528253-2F592302-815D-44C0-9836-743C20FA1F64

Q24528253-363982AD-7368-40DF-B53D-1325E92A018D

P304

Q24528253-9E4DA9B4-0646-4DFE-9D9A-E4DD34621DD2

P31

Q24528253-9117ED8B-7938-4349-ADE1-4EDE9E73E64F

P3181

Q24528253-26C16EFA-0833-4E68-8C8A-75A033B53580

P356

Q24528253-98F7E56C-621E-477E-BB73-C83FD6AA7E04

P407

Q24528253-312C90ED-EE3B-4E58-91C1-00FCE6C613D3

P433

Q24528253-37F6A7D6-902F-4ADC-8FD8-630EF9AE34BE

P478

Q24528253-377287F4-627E-4949-8F82-DFBFE88FAAFC

P577

Q24528253-3725D750-0585-486A-BBCE-ABC4F4B6D1CC

P698

Q24528253-85CDA915-E1E5-40DB-8C50-7217E4986A12

P921

Q24528253-9494EAB2-5F24-4927-BDE7-1FFB4051744A

P932

Q24528253-1FBB36C1-2B18-4F73-A648-45294ADD9FA5

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Microarray analysis identifies ...... with multiple types of cancer

@en

P2093

Anna B Glinskii

http://www.w3.org/2001/XMLSchema#string

Gennadi V Glinsky

http://www.w3.org/2001/XMLSchema#string

Olga Berezovska

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression

Cancerous stem cells can arise from pediatric brain tumors

Gene expression profiling predicts clinical outcome of prostate cancer

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

Prospective identification of tumorigenic breast cancer cells

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Systematic determination of genetic network architecture

P304

1503-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3142045

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI23412

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15931389

http://www.w3.org/2001/XMLSchema#string

P921

P932

1136989

http://www.w3.org/2001/XMLSchema#string